ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,853Medicare Part D Prescriptions Filled, Including Refills

Rank: 173 out of 890

$650K Total Retail Price of All Prescriptions

Rank: 171 out of 890

554 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 554 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

27% of this provider’s 554 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 8,388 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 743 417 S3 1 3
FUROSEMIDE 388 268 2 7
LISINOPRIL 344 234 3 4
ZOLPIDEM TARTRATE 304 187 4 19
AMLODIPINE BESYLATE 279 207 5 1
NEXIUM 278 206 6 14
SIMVASTATIN 272 240 7 5
POTASSIUM CHLORIDE 265 166 8 11
METFORMIN HCL 253 191 9 6
LEVOTHYROXINE SODIUM 246 227 10 2
OMEPRAZOLE 219 156 11 8
HYDROCHLOROTHIAZIDE 208 166 12 9
ATORVASTATIN CALCIUM 207 173 13 13
TRAMADOL HCL 185 148 14 16
PRAVASTATIN SODIUM 169 123 15 10
MELOXICAM 146 87 16 18
LYRICA 142 62 17 71
GABAPENTIN 136 85 18 12
METOPROLOL SUCCINATE 132 130 19 17
CLOPIDOGREL 127 113 20 28
CLONIDINE HCL 127 78 20 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 126 83 22 21
DONEPEZIL HCL 113 113 23 30
SERTRALINE HCL 105 70 24 26
GLIMEPIRIDE 105 90 24 27
DIOVAN HCT 102 90 26 48
ACTOS 94 83 27 88
CARVEDILOL 92 60 28 22
WARFARIN SODIUM 92 86 28 24
METOPROLOL TARTRATE 92 60 28 15
PLAVIX 89 76 31 42
RAMIPRIL 80 71 32 80
CITALOPRAM HBR 77 41 33 20
LIPITOR 75 46 34 77
RISPERIDONE 75 60 34 78
AZITHROMYCIN 74 57 36 37
CELEBREX 72 67 37 91
AMLODIPINE BESYLATE-BENAZEPRIL 69 56 38 41
LEVOCETIRIZINE DIHYDROCHLORIDE 69 51 38 131
ALLOPURINOL 68 56 40 31
BYSTOLIC 66 51 41 86
FLUTICASONE PROPIONATE 65 41 42 39
LANTUS 64 32 43 50
NAMENDA 63 63 44 36
CIPROFLOXACIN HCL 63 44 44 58
PHENYTOIN SODIUM EXTENDED 62 25 46 111
CARISOPRODOL 60 0 R 47 69
CARBIDOPA-LEVODOPA 60 60 47 136
CYMBALTA 60 16 47 45
COLCRYS 57 35 50 150
ENDOCET 57 0 S2 50 218
PANTOPRAZOLE SODIUM 54 50 52 34
PREMARIN 54 36 R 52 105
NIFEDIPINE ER 52 25 54 75
TRILIPIX 52 46 54 200
SINGULAIR 51 40 56 79
DIOVAN 51 48 56 33
CEFPROZIL 50 38 58 255
LANTUS SOLOSTAR 50 29 58 102
FLUOXETINE HCL 50 25 58 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.